Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Enjoy this offer
* See conditions under "Our services"

Valuation: Fresenius SE & Co. KGaA

Market Cap 20.94B 24.19B 19.3B 18.06B 33.69B 2,304B 34.45B 229B 88.93B 1,116B 90.8B 88.85B 3,881B P/E ratio 2026 *
11.1x
P/E ratio 2027 * 10x
Enterprise value 31.28B 36.15B 28.84B 26.98B 50.35B 3,444B 51.48B 343B 133B 1,668B 136B 133B 5,800B EV / Sales 2026 *
1.32x
EV / Sales 2027 * 1.23x
Free-Float
72.99%
Yield 2026 *
3.06%
Yield 2027 * 3.32%
1 day+1.40%
1 week+4.81%
Current month+3.92%
1 month-5.49%
3 months-21.97%
6 months-21.54%
Current year-23.05%
1 week 36.02
Extreme 36.02
37.86
1 month 35.11
Extreme 35.11
40.81
Current year 35.11
Extreme 35.11
52.96
1 year 35.11
Extreme 35.11
52.96
3 years 23.93
Extreme 23.93
52.96
5 years 19.69
Extreme 19.69
52.96
10 years 19.69
Extreme 19.69
80.07
Manager TitleAgeSince
Chief Executive Officer 57 01/10/2022
Director of Finance/CFO 46 01/09/2022
Compliance Officer 50 -
Director TitleAgeSince
Director/Board Member 71 20/05/2015
Director/Board Member 65 13/05/2016
Director/Board Member 52 01/01/2016
Date Insider Type Main position Quantity % Market Cap.
05-28Buy

Chief Executive Officer

968 0.0002%
05-28Buy

Chief Executive Officer

276 0.0000%
05-28Buy

Chief Executive Officer

1,571 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+1.40%+4.81%-14.30%+48.15% 24.2B
+0.48%+6.81%+51.87%+36.49% 124B
-0.62%+2.53%+2.06%+34.82% 83.17B
-0.30%+5.34%+14.98%+50.30% 22.64B
-0.33%-0.09%-16.89%-20.04% 20.07B
-2.03%-0.85%+4.39%+122.82% 14.33B
-2.19%-1.66%-9.96%-0.43% 14.14B
+0.06%+1.90%+42.87%+104.70% 12.72B
+0.52%+7.80%-22.53%-8.44% 11.99B
+0.68%+6.38%-15.41%+77.04% 10.24B
Average -0.26%+3.70%+3.71%+44.54% 33.73B
Weighted average by Cap. -0.07%+4.79%+18.64%+38.80%

Financials

2026 *2027 *
Net sales 23.62B 27.29B 21.78B 20.37B 38.01B 2,600B 38.87B 259B 100B 1,259B 102B 100B 4,379B 24.83B 28.69B 22.9B 21.42B 39.97B 2,734B 40.87B 272B 105B 1,324B 108B 105B 4,604B
Net income 1.89B 2.19B 1.75B 1.63B 3.05B 209B 3.12B 20.75B 8.05B 101B 8.22B 8.04B 351B 2.12B 2.45B 1.96B 1.83B 3.42B 234B 3.49B 23.25B 9.02B 113B 9.21B 9.01B 393B
Net Debt 10.35B 11.96B 9.54B 8.93B 16.66B 1,139B 17.03B 113B 43.96B 552B 44.89B 43.92B 1,919B 9.6B 11.09B 8.85B 8.28B 15.45B 1,057B 15.8B 105B 40.77B 512B 41.63B 40.74B 1,779B
Logo Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - hospital administration and engineering (59.2%; Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (37.7%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc.; - other (3.1%).
Employees
177,783
Date Price Change Volume
10/06/26 37.69 +1.40% 1,339,758
09/06/26 37.17 +0.68% 1,181,478
08/06/26 36.92 -0.91% 1,060,310
05/06/26 37.26 +1.61% 1,146,240
04/06/26 36.67 +1.97% 1,408,243
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
37.17EUR
Average target price
54.79EUR
Spread / Average Target
+47.41%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
BENEFIT NOW